Business Context and Reporting Period
This Form 8-K Current Report was filed by Maravai LifeSciences Holdings, Inc. on June 10, 2024. The filing addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of a director's resignation and contains no financial performance data.
Material Changes
The material change disclosed is the resignation of Anat Ashkenazi from the Board of Directors, effective July 31, 2024. The resignation is due to her pending appointment as Chief Financial Officer of Alphabet Inc. The Company explicitly states that the departure is not related to any disagreement with management or the Board regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, outlook, or management commentary on future performance. No new risks, contingencies, or unusual items were disclosed in this specific report.
Key Facts for Investor Verification
- Director Anat Ashkenazi will resign effective July 31, 2024.
- The resignation is driven by a new role as CFO at Alphabet Inc.
- The departure is confirmed to be unrelated to any internal disagreements.
- No financial results or operational metrics are included in this filing.